Back to BlackRock, Inc. BlackRock, Inc.

LYELLYEL
5 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in LYELL IMMUNOPHARMA INC

Yes. BlackRock holds 724,342 shares of LYEL (Lyell Immunopharma), worth $10.2M, as of its Q2 2026 13F filing. It increased the position from 191,820 shares in Q1 2026. BlackRock has held LYEL in every 13F on record since Q2 2025, 5 quarterly filings.

Current Value

$10.2M

Current Shares

724,342

Total Value Change

+$8.9M

Total Shares Change

+579,483

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
724,342
+277.6%
$10.2M0.0%$14.05
45
2026-Q1
Increased
191,820
+5.5%
$3.8M0.0%$23.33
28
2025-Q4
Increased
181,837
+2.9%
$5.6M0.0%$31.59
28
2025-Q3
Increased
176,806
+22.1%
$2.9M0.0%$14.97
32
2025-Q2
New
144,859
-
$1.3M0.0%$8.94
39

Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used